World's Best Scientists 2026 revealed!
Mauro Moroni

Mauro Moroni

D-Index & Metrics

Microbiology

D-Index
56
Citations
10443
World Ranking
3715
National Ranking
111

Mauro Moroni publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mauro Moroni sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 238 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mauro Moroni D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mauro Moroni sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 56 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mauro Moroni was affiliated with the University of Milan in Italy. Their research primarily focused on medicine, with a concentration in oncology, pulmonary and respiratory medicine, hematology, genetics, and molecular biology.

Their work covered a range of topics, including:

  • Colorectal Cancer Treatments and Studies
  • Erythropoietin and Anemia Treatment
  • Iron Metabolism and Disorders
  • Hemoglobinopathies and Related Disorders
  • Cancer Cells and Metastasis
  • HER2/EGFR in Cancer Research
  • Lung Cancer Treatments and Mutations

Mauro Moroni contributed to several publications with notable papers such as:

  • "A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)," 2021, Breast Cancer Research and Treatment
  • "A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer," 2022, Nutrients
  • "Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial," 2021, European Journal of Cancer
  • "Lycopene minimizes skin toxicity and oxidative stress in patients treated with panitumumab-containing therapy for metastatic colorectal cancer," 2021, Journal of Functional Foods
  • "Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial," 2020, Therapeutic Advances in Medical Oncology

The researcher collaborated frequently with several colleagues, including:

  • Paolo Pedrazzoli
  • Alessandra Ferrari
  • Salvatore Artale
  • Riccardo Caccialanza
  • Gerardo Rosati

Mauro Moroni's publications appeared in various venues, reflecting a range of subfields in medicine. These included:

  • Breast Cancer Research and Treatment
  • Nutrients
  • European Journal of Cancer
  • Journal of Functional Foods
  • Therapeutic Advances in Medical Oncology

Best Publications

  • Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.

    A d'Arminio Monforte;A C Lepri;G Rezza;P Pezzotti

  • Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

    Adriana Ammassari;Rita Murri;Patrizio Pezzotti;Maria Paola Trotta

  • Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

    Cristina Gervasoni;Anna Lisa Ridolfo;Giuliana Trifirò;Sara Santambrogio

  • Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

    Patrizia Comoli;Paolo Pedrazzoli;Rita Maccario;Sabrina Basso

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Risk of Kaposi's Sarcoma-Associated Herpes Virus Transmission From Donor Allografts Among Italian Posttransplant Kaposi's Sarcoma Patients

    Carlo Parravicini;Sonja J. Olsen;Maria Capra;Francesca Poli

  • Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.

    d'Arminio Monforte A;Testa L;Adorni F;Chiesa E

  • Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.

    Mario Corbellino;Giovanna Bestetti;Chiara Scalamogna;Sara Calattini

  • Homozygous Δ32 deletion of the Ccr-5 chemokine receptor gene in an Hiv-1-infected patient

    Claudia Balotta;Patrizia Bagnarelli;Michela Violin;Anna Lisa Ridolfo

  • Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses.

    Massimo Arlotti;Paolo Grossi;Federico Pea;Giustino Tomei

  • When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study.

    A Cozzi Lepri;A N Phillips;A d'Arminio Monforte;F Castelli

  • Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors.

    Massimo Galli;Anna Lisa Ridolfo;Fulvio Adorni;Cristina Gervasoni

  • Cortisol resistance in acquired immunodeficiency syndrome

    G Norbiato;M Bevilacqua;T Vago;G Baldi

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma.

    Carlo Parravicini;Eleonora Lauri;Luca Baldini;Antonino Neri

  • Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

    Michela Violin;Alessandro Cozzi-Lepri;Rossella Velleca;Antonella Vincenti

  • Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.

    Cristina Mussini;Patrizio Pezzotti;Alessandra Govoni;Vanni Borghi

  • Type 1 Cytokine Production and Low Prevalence of Viral Isolation Correlate with Long-Term Nonprogression in HIV Infection

    Mario Clerici;Claudia Balotta;Luca Meroni;Enrica Ferrario

  • Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

    S. Rusconi;S. La Seta Catamancio;P. Citterio;S. Kurtagic

  • Role of PCR in Diagnosis and Prognosis of Visceral Leishmaniasis in Patients Coinfected with Human Immunodeficiency Virus Type 1

    Massimo Pizzuto;Manuela Piazza;Daniela Senese;Chiara Scalamogna

  • Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.

    Antonella D Arminio Monforte;Roberto Bugarini;Patrizio Pezzotti;Andrea De Luca

  • Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): A correlative morphologic and clinical study in 26 consecutive fatal cases

    Giorgio Baroldi;Salvatore Corallo;Mauro Moroni;Alberto Repossini

Frequent Co-Authors

Massimo Galli
Massimo Galli University of Milan
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Spinello Antinori
Spinello Antinori University of Milan
Claudia Balotta
Claudia Balotta University of Milan
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Mario Clerici
Mario Clerici University of Milan
Andrea Gori
Andrea Gori University of Milan
Giuseppe Ippolito
Giuseppe Ippolito Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Giampiero Carosi
Giampiero Carosi University of Brescia
Luca Vago
Luca Vago Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Microbiology in the USA opens doors to various related fields, especially in healthcare and information management. Many students consider expanding their expertise with certifications like the cpc certification salary and career opportunities. This certification can complement a microbiology background by enhancing skills in medical coding and billing, crucial for healthcare administration.

For those interested in data management and healthcare systems, pursuing a health information management degree salary reflects the growing demand for professionals skilled in managing patient data and health records. This degree aligns well with microbiology graduates looking to enter healthcare management or health informatics fields.

Finding the right program is essential, and many choose the best cahiim accredited him programs online for reputable education that meets industry standards. These online options offer flexibility for students balancing studies and work.

For quick entry into the healthcare field, consider the quickest medical billing and coding certificate online. These programs provide efficient pathways to certification, enabling graduates to start careers promptly while complementing their microbiology knowledge.

Best Scientists Citing Mauro Moroni

Recently Published Articles